Evaluating the educational quality and reliability of YouTube videos on red light therapy for eye diseases. | ScholarDeck

Paper

Evaluating the educational quality and reliability of YouTube videos on red light therapy for eye diseases.

New research · Ophthalmology

Lasers in medical science · 1mo

StudyLasers in medical science· Jun 2026

Evaluating the educational quality and reliability of YouTube videos on red light therapy for eye diseases.

Elvin Çelenk, Işıl Merve Torun

Read paper

RetinaStudyQ2IF 2.8

Only 17.5% of YouTube red light therapy eye videos were high-quality

Evaluating the educational quality and reliability of YouTube videos on red light therapy for eye diseases.

Elvin Çelenk, Işıl Merve Torun

Lasers in medical science · Jun 2026

Purpose

To investigate the use of YouTube videos as an educational and informational resource regarding the use of red light therapy in eye diseases.

Results

checked against a formal quality checklist, most videos fell short

82.5%

Low-to-moderate qualit

17.5%

High quality

More results

Out of 110 YouTube videos reviewed, 53 were excluded based on predefined criteria.

The remaining 57 videos covered myopia (22.8%), dry eye (33.3%), diabetic retinopathy (12.3%), and age-related macular degeneration (31.6%).

Inter-rater agreement was high (mDISCERN ICC: 0.952; JAMA ICC: 0.923; Global Quality Score ICC: 0.890).

More results

A moderate positive correlation was found between the number of likes and the interaction index (r = 0.458, p < 0.01).

“

Conclusion

More evidence-based and accessible video content is needed to support patient education.

Read paper

0 comments

No comments yet. Be the first.

ScholarDeck.

Join the discussion on this paper

Create your profile

Related papers

Latest Foundational

AI / Informatics

0·962 for OCT

MerMED-FM was very accurate at diagnosing diseases using eye scans

Case Report

“Idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome may be complicated by cilioretinal artery occlusion, resulting in poor final visual acuity despite reperfusion of the occluded artery.”

Review

20/20

normal vision achieved in one eye

Study

20/40

visual acuity was half of normal in both eyes

Cohort Study

7-year

adalimumab showed no new safety signals in this long-term extension

Cohort Study

25%

One-quarter of patients with head and neck sebaceous gland carcinoma had confirmed nodal metastasis.

Cohort Study

410°

wider field of binocular single vision after combined surgery

Guideline

“The increased incidence of postoperative complications should be taken into account when considering a surgical management.”